FY13 Office of the Chief Medical Office - Grace Drug Standards

The District of Columbia's Office of the Chief Medical Examiner issued a procurement opportunity identified by contract ID 66c85d68829eb5d8690749a8 for FY13 Grace Drug Standards. This solicitation appears to be focused on drug standards and related services for the medical examiner's office, though specific details about precise deliverables are limited in the provided information. The contract was posted and due on June 27, 2013, indicating an expedited procurement timeline with simultaneous posting and closing dates. Given the nature of the opportunity being linked to the medical examiner's office, the procurement likely involves forensic or medical testing standards, drug analysis protocols, or related professional services. The compressed timeline suggests this might have been an urgent or time-sensitive procurement requiring immediate vendor response.

While specific set-aside designations or disadvantaged enterprise requirements are not evident in the provided documentation, the District of Columbia typically maintains standard local procurement guidelines that may include such provisions. No incumbent vendors or current contractors are identified in the available information. Similarly, no specific budget range or award value is disclosed in the contract opportunity details. The procurement appears to be specifically targeted to the District of Columbia's governmental needs, potentially limiting participation to vendors with appropriate local credentials or experience in forensic or medical standards implementation. Given the specialized nature of the Office of the Chief Medical Examiner, prospective vendors would likely need demonstrable expertise in medical, forensic, or drug standards development and implementation.